|
|
|
Insider
Information: |
Mahoney David L |
Relationship: |
Director |
City: |
Cupertino |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
212,270 |
|
Indirect Shares
|
1,261,596 |
|
|
Direct
Value |
$5,146,241 |
|
|
Indirect Value
|
$34,708,434 |
|
|
Total
Shares |
1,473,866 |
|
|
Total
Value |
$39,854,675 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-19.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Symantec Corp |
SYMC |
Director |
2018-05-17 |
184,464 |
2018-05-17 |
2,835 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
|
2024-04-10 |
27,806 |
2024-04-10 |
1,258,761 |
Premium* |
|
Adamas Pharmaceuticals Inc |
ADMS |
Director |
2021-11-24 |
0 |
2021-11-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CORT |
Corcept Therapeutics Inc |
|
|
2023-08-29 |
4 |
GA |
$0.00 |
$0 |
I/I |
34,850 |
46,147 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
|
|
2023-08-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
52,270 |
1,169,808 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
|
|
2024-04-10 |
4 |
A |
$0.00 |
$0 |
I/I |
27,806 |
1,212,614 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
|
|
2024-04-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(27,806) |
27,806 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-13 |
4/A |
OE |
$2.23 |
$1,079 |
I/I |
484 |
1,136,157 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-13 |
4 |
AS |
$12.55 |
$6,073 |
I/I |
(484) |
1,128,679 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-13 |
4/A |
AS |
$12.55 |
$6,073 |
I/I |
(484) |
1,135,673 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2008-11-11 |
4 |
A |
$1.45 |
$10,133 |
I/I |
6,988 |
643,535 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-18 |
4 |
OE |
$2.23 |
$13,583 |
I/I |
6,091 |
1,141,764 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-12 |
4/A |
OE |
$2.23 |
$14,517 |
I/I |
6,510 |
1,142,183 |
0 |
- |
|
SYMC |
Symantec Corp |
officerTitle |
|
2005-04-25 |
4 |
A |
$19.07 |
$24,982 |
D/D |
1,310 |
8,852 |
|
- |
|
SYMC |
Symantec Corp |
Director |
|
2006-04-25 |
4 |
A |
$16.04 |
$24,990 |
D/D |
1,558 |
20,410 |
|
- |
|
SYMC |
Symantec Corp |
Director |
|
2004-04-27 |
4/A |
A |
$48.91 |
$24,993 |
D/D |
511 |
3,771 |
|
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Director |
|
2021-03-12 |
4 |
OE |
$0.67 |
$31,920 |
D/D |
48,000 |
110,153 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2017-07-19 |
4 |
OE |
$2.23 |
$37,720 |
I/I |
16,915 |
1,152,588 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2019-06-03 |
4 |
OE |
$0.96 |
$48,000 |
D/D |
50,000 |
50,000 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2006-02-21 |
4 |
B |
$4.99 |
$49,890 |
I/I |
10,000 |
50,700 |
2.1 |
- |
|
SYMC |
Symantec Corp |
Director |
|
2016-05-17 |
4 |
A |
$0.00 |
$49,990 |
D/D |
19,184 |
166,386 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2023-05-08 |
4 |
OE |
$1.74 |
$52,200 |
I/I |
30,000 |
1,239,275 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
|
|
2024-04-10 |
4 |
OE |
$1.74 |
$52,200 |
D/D |
30,000 |
30,000 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2023-05-08 |
4 |
D |
$23.76 |
$52,201 |
I/I |
(2,197) |
1,237,078 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
|
|
2024-04-10 |
4 |
D |
$23.80 |
$52,217 |
D/D |
(2,194) |
27,806 |
0 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2004-11-08 |
4 |
B |
$5.35 |
$53,461 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
CORT |
Corcept Therapeutics Inc |
Director |
|
2006-02-17 |
4 |
B |
$5.07 |
$54,293 |
I/I |
10,700 |
40,700 |
2.1 |
- |
|
ADMS |
Adamas Pharmaceuticals In... |
Director |
|
2019-09-17 |
4 |
OE |
$1.76 |
$58,498 |
D/D |
33,332 |
57,153 |
0 |
- |
|
85 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|